Convalescent plasma therapy in an immunocompromised patient with multiple COVID-19 flares: a case report.

Authors :: Karaolidou F
Loutsidi NE
Mellios Z
Jahaj E
Eleftheriou K
Pagoni M
Mpaltadakis I
Dimopoulos AM
Kalomenidis I
Pappas AG
Source :: Respirology case reports [Respirol Case Rep] 2021 Nov 09; Vol. 9 (12), pp. e0858. Date of Electronic Publication: 2021 Nov 09 (Print Publication: 2021).
Publication Year :: 2021
Abstract: Convalescent plasma (CP) transfusion has been utilized as a salvage therapy in immunocompromised patients with severe COVID-19 pneumonia. We describe the case of a 45-year-old immunocompromised patient, who received CP, in order to control multiple COVID-19 flares and prolonged SARS-CoV-2 viraemia lasting for 2 months after the initial diagnosis.<br />Competing Interests: None declared.<br /> (© 2021 The Authors. Respirology Case Reports published by John Wiley & Sons Australia, Ltd on behalf of The Asian Pacific Society of Respirology.)

Full Text Access

Tools